Clicky

Alector, Inc.(ALEC)

Description: Alector is pioneering immuno-neurology, a novel therapeutic approach to counteract the multiple pathologies that cause degenerative brain disorders by restoring healthy immune function to the brain. Supporting its scientific approach, the Company’s Discovery Platform enables them to advance a broad portfolio of product candidates, validated by human genetics, which they believe will improve the probability of technical success of these product candidates and shorten the development timelines to bring these therapies to patients.


Keywords: Immunology Immune System Genetics Urology Neurology Brain Disorders

Home Page: www.alector.com

ALEC Technical Analysis

131 Oyster Point Boulevard
South San Francisco, CA 94080
United States
Phone: 415 231 5660


Officers

Name Title
Dr. Tillman Ulf Gerngross Ph.D. Co-Founder & Chairman
Dr. Arnon Rosenthal Ph.D. Co-Founder, CEO & Director
Dr. Sara Kenkare-Mitra Ph.D. Pres and Head of R&D
Mr. Calvin Yu VP of Fin.
Dr. Marc Grasso M.D. Chief Financial Officer
Mr. Peter Heutink Ph.D. Chief Scientific Officer
Michelle Corral VP of Communications & Investor Relations
Ms. Danielle Pasqualone J.D., Ph.D. Gen. Counsel
Erica Jefferson VP of Communications & Public Affairs
Ms. Clare Hunt M.B.A. Chief People Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 526.3158
Trailing PE: 13.5167
Price-to-Book MRQ: 3.0649
Price-to-Sales TTM: 5.4898
IPO Date: 2019-02-07
Fiscal Year End: December
Full Time Employees: 269
Back to stocks